Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139,526 | 167,467 | 92,302 | 173,984 | 41,731 |
| Marketable Securities | N/A | 34,837 | 38,067 | N/A | 49,975 |
| Receivables | N/A | N/A | N/A | 7 | 20,000 |
| Other current assets | 0 | 1,694 | 2,979 | 2,324 | 158 |
| TOTAL | $144,980 | $211,392 | $136,585 | $178,557 | $114,513 |
| Non-Current Assets | |||||
| PPE Net | 7,298 | 11,353 | 12,844 | 14,213 | 15,210 |
| Investments And Advances | 0 | 0 | 13,038 | 0 | 0 |
| Other Non-Current Assets | 15,896 | 21,741 | 20,468 | 20,480 | 20,255 |
| TOTAL | $23,194 | $33,094 | $46,350 | $34,693 | $35,465 |
| Total Assets | $168,174 | $244,486 | $182,935 | $213,250 | $149,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,667 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 11,544 | 6,411 | 3,692 | 3,603 | 5,853 |
| Accrued Expenses | 16,146 | 17,966 | 15,624 | 11,084 | 10,646 |
| TOTAL | $36,681 | $30,778 | $31,508 | $28,624 | $23,516 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,556 | 40,649 | 40,257 | 39,551 | N/A |
| Deferred Revenues | N/A | 4,330 | 10,181 | 12,209 | 5,739 |
| Other Non-Current Liabilities | 80,275 | 45,323 | 25,887 | 44,289 | 24,018 |
| TOTAL | $114,831 | $85,972 | $66,209 | $94,073 | $47,278 |
| Total Liabilities | $151,512 | $116,750 | $97,717 | $122,697 | $70,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,454 | 20,300 | 6,208 | 6,164 | 4,340 |
| Common Shares | 26 | 20 | 6 | 56 | 43 |
| Retained earnings | -722,807 | -558,233 | -463,579 | -377,021 | -292,983 |
| Other shareholders' equity | 0 | 102 | -79 | 0 | 24 |
| TOTAL | $16,662 | $127,736 | $85,218 | $90,553 | $79,184 |
| Total Liabilities And Equity | $168,174 | $244,486 | $182,935 | $213,250 | $149,978 |